Report Detail

Pharma & Healthcare Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2021-2027

  • RnM2294711
  • |
  • 19 January, 2021
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Ophthalmic Therapeutics/Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Anti-allergy
    • 1.2.3 Anti-VEGF Agents
    • 1.2.4 Anti-inflammatory
    • 1.2.5 Anti-glaucoma
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Ophthalmic Therapeutics/Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Dry Eye
    • 1.3.3 Allergies
    • 1.3.4 Glaucoma
    • 1.3.5 Infection
    • 1.3.6 Retinal Disorders
    • 1.3.7 Uveitis
    • 1.3.8 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Ophthalmic Therapeutics/Drug Market Perspective (2016-2027)
  • 2.2 Ophthalmic Therapeutics/Drug Growth Trends by Regions
    • 2.2.1 Ophthalmic Therapeutics/Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Ophthalmic Therapeutics/Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Ophthalmic Therapeutics/Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Ophthalmic Therapeutics/Drug Industry Dynamic
    • 2.3.1 Ophthalmic Therapeutics/Drug Market Trends
    • 2.3.2 Ophthalmic Therapeutics/Drug Market Drivers
    • 2.3.3 Ophthalmic Therapeutics/Drug Market Challenges
    • 2.3.4 Ophthalmic Therapeutics/Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue
    • 3.1.1 Global Top Ophthalmic Therapeutics/Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Ophthalmic Therapeutics/Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Ophthalmic Therapeutics/Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Ophthalmic Therapeutics/Drug Revenue
  • 3.4 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio
    • 3.4.1 Global Ophthalmic Therapeutics/Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Therapeutics/Drug Revenue in 2020
  • 3.5 Ophthalmic Therapeutics/Drug Key Players Head office and Area Served
  • 3.6 Key Players Ophthalmic Therapeutics/Drug Product Solution and Service
  • 3.7 Date of Enter into Ophthalmic Therapeutics/Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Ophthalmic Therapeutics/Drug Breakdown Data by Type

  • 4.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Type (2022-2027)

5 Ophthalmic Therapeutics/Drug Breakdown Data by Application

  • 5.1 Global Ophthalmic Therapeutics/Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Ophthalmic Therapeutics/Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Ophthalmic Therapeutics/Drug Market Size (2016-2027)
  • 6.2 North America Ophthalmic Therapeutics/Drug Market Size by Type
    • 6.2.1 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
  • 6.3 North America Ophthalmic Therapeutics/Drug Market Size by Application
    • 6.3.1 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
  • 6.4 North America Ophthalmic Therapeutics/Drug Market Size by Country
    • 6.4.1 North America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Ophthalmic Therapeutics/Drug Market Size (2016-2027)
  • 7.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type
    • 7.2.1 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
  • 7.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application
    • 7.3.1 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
  • 7.4 Europe Ophthalmic Therapeutics/Drug Market Size by Country
    • 7.4.1 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type
    • 8.2.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application
    • 8.3.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region
    • 8.4.1 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Ophthalmic Therapeutics/Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Ophthalmic Therapeutics/Drug Market Size (2016-2027)
  • 9.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type
    • 9.2.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application
    • 9.3.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Ophthalmic Therapeutics/Drug Market Size by Country
    • 9.4.1 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type
    • 10.2.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application
    • 10.3.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country
    • 10.4.1 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Ophthalmic Therapeutics/Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Alcon
    • 11.1.1 Alcon Company Details
    • 11.1.2 Alcon Business Overview
    • 11.1.3 Alcon Ophthalmic Therapeutics/Drug Introduction
    • 11.1.4 Alcon Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.1.5 Alcon Recent Development
  • 11.2 Johnson and Johnson Vision Care, Inc.
    • 11.2.1 Johnson and Johnson Vision Care, Inc. Company Details
    • 11.2.2 Johnson and Johnson Vision Care, Inc. Business Overview
    • 11.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Introduction
    • 11.2.4 Johnson and Johnson Vision Care, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.2.5 Johnson and Johnson Vision Care, Inc. Recent Development
  • 11.3 Bausch & Lomb Incorporated
    • 11.3.1 Bausch & Lomb Incorporated Company Details
    • 11.3.2 Bausch & Lomb Incorporated Business Overview
    • 11.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Introduction
    • 11.3.4 Bausch & Lomb Incorporated Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.3.5 Bausch & Lomb Incorporated Recent Development
  • 11.4 Novartis AG
    • 11.4.1 Novartis AG Company Details
    • 11.4.2 Novartis AG Business Overview
    • 11.4.3 Novartis AG Ophthalmic Therapeutics/Drug Introduction
    • 11.4.4 Novartis AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.4.5 Novartis AG Recent Development
  • 11.5 Merck Sharp & Dohme Corp.
    • 11.5.1 Merck Sharp & Dohme Corp. Company Details
    • 11.5.2 Merck Sharp & Dohme Corp. Business Overview
    • 11.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Introduction
    • 11.5.4 Merck Sharp & Dohme Corp. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.5.5 Merck Sharp & Dohme Corp. Recent Development
  • 11.6 Regeneron Pharmaceuticals Inc.
    • 11.6.1 Regeneron Pharmaceuticals Inc. Company Details
    • 11.6.2 Regeneron Pharmaceuticals Inc. Business Overview
    • 11.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Introduction
    • 11.6.4 Regeneron Pharmaceuticals Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.6.5 Regeneron Pharmaceuticals Inc. Recent Development
  • 11.7 Allergan
    • 11.7.1 Allergan Company Details
    • 11.7.2 Allergan Business Overview
    • 11.7.3 Allergan Ophthalmic Therapeutics/Drug Introduction
    • 11.7.4 Allergan Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.7.5 Allergan Recent Development
  • 11.8 Pfizer Inc.
    • 11.8.1 Pfizer Inc. Company Details
    • 11.8.2 Pfizer Inc. Business Overview
    • 11.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Introduction
    • 11.8.4 Pfizer Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.8.5 Pfizer Inc. Recent Development
  • 11.9 Valeant
    • 11.9.1 Valeant Company Details
    • 11.9.2 Valeant Business Overview
    • 11.9.3 Valeant Ophthalmic Therapeutics/Drug Introduction
    • 11.9.4 Valeant Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.9.5 Valeant Recent Development
  • 11.10 Bayer AG
    • 11.10.1 Bayer AG Company Details
    • 11.10.2 Bayer AG Business Overview
    • 11.10.3 Bayer AG Ophthalmic Therapeutics/Drug Introduction
    • 11.10.4 Bayer AG Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.10.5 Bayer AG Recent Development
  • 11.11 Santen Pharmaceuticals Co. Ltd
    • 11.11.1 Santen Pharmaceuticals Co. Ltd Company Details
    • 11.11.2 Santen Pharmaceuticals Co. Ltd Business Overview
    • 11.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics/Drug Introduction
    • 11.11.4 Santen Pharmaceuticals Co. Ltd Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.11.5 Santen Pharmaceuticals Co. Ltd Recent Development
  • 11.12 Genentech, Inc.
    • 11.12.1 Genentech, Inc. Company Details
    • 11.12.2 Genentech, Inc. Business Overview
    • 11.12.3 Genentech, Inc. Ophthalmic Therapeutics/Drug Introduction
    • 11.12.4 Genentech, Inc. Revenue in Ophthalmic Therapeutics/Drug Business (2016-2021)
    • 11.12.5 Genentech, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Ophthalmic Therapeutics/Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Therapeutics/Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Anti-allergy
    Anti-VEGF Agents
    Anti-inflammatory
    Anti-glaucoma
    Others

    Segment by Application
    Dry Eye
    Allergies
    Glaucoma
    Infection
    Retinal Disorders
    Uveitis
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Alcon
    Johnson and Johnson Vision Care, Inc.
    Bausch & Lomb Incorporated
    Novartis AG
    Merck Sharp & Dohme Corp.
    Regeneron Pharmaceuticals Inc.
    Allergan
    Pfizer Inc.
    Valeant
    Novartis AG
    Merck Sharp & Dohme Corp.


    Summary:
    Get latest Market Research Reports on Ophthalmic Therapeutics/Drug . Industry analysis & Market Report on Ophthalmic Therapeutics/Drug is a syndicated market report, published as Global Ophthalmic Therapeutics/Drug Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Ophthalmic Therapeutics/Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,844.29
    4,266.43
    5,688.58
    3,276.83
    4,915.24
    6,553.65
    427,810.50
    641,715.75
    855,621.00
    291,607.68
    437,411.52
    583,215.36
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report